Gilead Sciences (GILD) reported $6.67 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.3%. EPS of $1.81 for the same period compares to -$1.32 a year ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback